Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Mitogen-activated protein kinase 14 | ||
| Ligand | BDBM50357917 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_787640 (CHEMBL1918093) | ||
| IC50 | 9±n/a nM | ||
| Citation |  Lumeras, W; Vidal, L; Vidal, B; Balagué, C; Orellana, A; Maldonado, M; Domínguez, M; Segarra, V; Caturla, F 1,7-Naphthyridine 1-oxides as novel potent and selective inhibitors of p38 mitogen activated protein kinase. J Med Chem54:7899-910 (2011) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Mitogen-activated protein kinase 14 | |||
| Name: | Mitogen-activated protein kinase 14 | ||
| Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta | ||
| Type: | Serine/threonine-protein kinase | ||
| Mol. Mass.: | 41286.76 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | Q16539 | ||
| Residue: | 360 | ||
| Sequence: |
| ||
| BDBM50357917 | |||
| n/a | |||
| Name | BDBM50357917 | ||
| Synonyms: | CHEMBL1916531 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C24H19Cl3N2O3 | ||
| Mol. Mass. | 489.778 | ||
| SMILES | CCOCCOc1cc(-c2ccccc2Cl)c2cc[n+]([O-])c(-c3c(Cl)cccc3Cl)c2n1 |(39.4,-4.5,;38.07,-5.26,;36.74,-4.49,;35.4,-5.26,;34.07,-4.48,;32.73,-5.25,;31.4,-4.48,;31.4,-2.93,;30.07,-2.15,;30.07,-.62,;31.4,.15,;31.4,1.69,;30.07,2.46,;28.73,1.68,;28.74,.15,;27.41,-.63,;28.73,-2.93,;27.4,-2.16,;26.07,-2.93,;26.07,-4.48,;24.73,-5.25,;27.4,-5.25,;27.41,-6.78,;26.07,-7.55,;24.74,-6.78,;26.07,-9.09,;27.41,-9.86,;28.75,-9.08,;28.74,-7.54,;30.07,-6.77,;28.73,-4.47,;30.06,-5.24,)| | ||
| Structure | 
| ||